Wegovy vs Zepbound: which one should I ask for and where do I get either online?

Short answer

• Both are prescription weekly injectables that work well for weight loss. Zepbound (tirzepatide, Eli Lilly) has generally produced larger average weight loss in clinical trials than Wegovy (semaglutide 2.4 mg, Novo Nordisk), but individual response and side effects vary.
• Which to ask for depends on your medical history (especially type 2 diabetes), tolerance for GI side effects, and insurance/coverage. See next section for how to decide and where to get them online.

How to choose (practical guidance)

• If you have type 2 diabetes or need stronger blood‑sugar lowering in addition to weight loss: ask your clinician about Zepbound (tirzepatide). Tirzepatide has shown greater average weight loss and stronger glucose lowering in trials.
• If you don’t have diabetes and want a medication with a longer track record specifically for weight management, or you didn’t tolerate GLP‑1s before: ask about Wegovy (semaglutide). Some people tolerate semaglutide better.
• Consider side effects: both commonly cause nausea, vomiting, diarrhea, constipation; tirzepatide can cause similar or sometimes more GI effects. Both carry warnings (e.g., thyroid C‑cell tumor risk in rodents, possible pancreatitis) and are not recommended in pregnancy. Discuss personal/family thyroid cancer history and pregnancy plans with your clinician.
• Cost/coverage: insurance often requires prior authorization and may cover one drug and not the other. Manufacturer savings or patient‑assistance programs can help.

Where to get them online (reputable options)

• Manufacturer sites (start here for product info and patient support)
  • Wegovy (Novo Nordisk): Wegovy.com — has dosing info, savings card and patient support enrollment.
  • Zepbound (Eli Lilly): Zepbound.com — product info plus Lilly’s support/savings program.
• Telehealth weight‑management programs (they evaluate you and can prescribe when appropriate)
  • Calibrate (calibrate.com) — telehealth program focused on metabolic/weight care; has clinical oversight and has arranged GLP‑1 prescriptions.
  • Other national telemedicine providers that offer obesity medicine consultations (availability varies by state) — check reviews and whether they use board‑certified obesity medicine/endocrinology clinicians.
• Local providers and specialty pharmacies
  • Ask your primary care doctor, endocrinologist, or an obesity medicine specialist (find local specialists through the Obesity Medicine Association: obmed.org/find-a-doc).
  • Once prescribed, the prescription is typically filled through major pharmacy chains (CVS, Walgreens, Walmart) or specialty/mail pharmacies (Accredo, OptumRx, CVS Specialty). These handle refrigerated injectables and insurance coordination.
• Financial help and safety
  • Check the manufacturer co‑pay/savings programs and patient assistance if uninsured. Both Wegovy and Zepbound have manufacturer support pages.
  • Do not buy these drugs from online marketplaces (Amazon, eBay, international sellers) without a legitimate prescription—risk of counterfeit or mishandled medication.

Next steps I recommend

1. Talk with your PCP or an endocrinologist/obesity medicine doctor and say: “I’m interested in GLP‑1/GIP‑GLP therapy for weight loss — can we discuss Wegovy (semaglutide) versus Zepbound (tirzepatide) and which is best for me?”
2. Tell them about diabetes, heart disease, pregnancy plans, family history of thyroid cancer, and any prior experience with GLP‑1 medications.
3. If you want, I can help draft a short message you can send your provider or a telehealth intake form asking about these options.

If you want a specific recommendation now, tell me: do you have type 2 diabetes or any of the conditions above (pregnancy, family thyroid cancer, pancreatitis, etc.)?